Peripheral arterial disease: adverse impacts, disparities in outcomes, and the path ahead
Listen to this summary
This paper aims to address the adverse impacts of peripheral arterial disease (PAD) and the disparities in outcomes among affected populations. The authors highlight the significant individual and societal burdens of PAD, particularly on underserved groups, and propose both short-term and long-term strategies to improve management and access to care, including enhanced awareness and multidisciplinary treatment approaches. The study emphasizes the need for targeted interventions to reduce the prevalence and consequences of PAD, especially in vulnerable communities.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Lancet (London, England)
View all →Sep 22, 2026 · Lancet (London, England)
Current advancements in the care of peripheral arterial disease: modern approaches to medical, endovascular, and surgical treatment
Sep 22, 2026 · Lancet (London, England)
Understanding peripheral arterial disease in the current era
Sep 21, 2026 · Lancet (London, England)
Developing roadmaps for advancing practice, research, and policy in the arts and health
Sep 18, 2026 · Lancet (London, England)
Precision prevention and early detection: framework for a new clinical cancer control pathway
Sep 17, 2026 · Lancet (London, England)
Switch to injectable cabotegravir-rilpivirine given every 8 weeks in adolescents living with HIV with virological suppression in sub-Saharan Africa (LATA): a randomised, open-label, multicentre, 96-week non-inferiority trial
Sep 13, 2026 · Lancet (London, England)
Most-favoured-nation pricing for prescription drugs in US Medicare: a cohort study
More in Nuclear Medicine
View all →Sep 23, 2026 · The New England journal of medicine
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Sep 23, 2026 · The New England journal of medicine
Etuvetidigene Autotemcel for the Treatment of Wiskott-Aldrich Syndrome
Sep 23, 2026 · The New England journal of medicine
Clinical Uses of Common Genetic Variants Associated with Common Diseases
Sep 23, 2026 · The New England journal of medicine
Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
Sep 18, 2026 · Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
CMR and FDG PET/CT Imaging Phenotypes and their Association with Outcomes in Patients with Known or Suspected Myocarditis
Sep 14, 2026 · The New England journal of medicine
Tambotatug Pelitecan in Small-Cell Lung Cancer after Platinum-Based Therapy
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


